IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE) - Eyerich, Kilian; Weisenseel, Peter; Pinter, Andreas; Schäkel, Knut; Asadullah, Khusru; Wegner, Sven; Muñoz-Elias, Ernesto J.; Bartz, Holger; Taut, Friedmann J. H.; Reich, Kristian (BMJ open, 2021)
Gesehen am 11.11.2021